Bristol Myers Squibb CEO Chris Boerner tells ET Prime that India’s pharma talent pool is exceptionally strong. He also highlights the company’s push to become one of the fastest-growing firms by decade’s end, with AI playing a key role. Boerner says the approach could lead to truly transformational medicines while the company expands its footprint in India.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
